antibiotics

Forge, Roche Enter Antibiotic Alliance
Forge, Roche Enter Antibiotic Alliance
Contract Pharma
Roche
Forge Therapeutics
antibiotics
drug development
FG-LpxC LUNG
lung infections
Flag link:
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Endpoints
antibiotics
Tetraphase
M&A
AcelRx
Flag link:
Melinta's Bankruptcy Underlines Problems with the Antibiotics Market
Melinta's Bankruptcy Underlines Problems with the Antibiotics Market
BioSpace
Melinta Therapeutics
bankruptcy
antibiotics
Flag link:
New Antibiotics Face Major Development And Reimbursement Hurdles
New Antibiotics Face Major Development And Reimbursement Hurdles
Forbes
antibiotic resistance
antibiotics
drug-resistant infections
drug development
reimbursement
Flag link:
Certain GSK antibiotic brands are up for sale — report
Certain GSK antibiotic brands are up for sale — report
Endpoints
GSK
antibiotics
Flag link:
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Fierce Pharma
Sandoz
generics
antibiotics
COVID-19
coronaviruses
Flag link:
Bankrupt antibiotics maker Aradigm turns to old partner/investor for final $3M fire sale
Bankrupt antibiotics maker Aradigm turns to old partner/investor for final $3M fire sale
Endpoints
Grifols
antibiotics
Aradigm
Flag link:
Too Many Antibiotics Prescribed With No Doctor’s Visit, Study Finds
Too Many Antibiotics Prescribed With No Doctor’s Visit, Study Finds
Forbes
antibiotics
physicians
Flag link:
Novo Holdings tweaks fund to take antibiotics deeper into the clinic
Novo Holdings tweaks fund to take antibiotics deeper into the clinic
Fierce Biotech
Novo Holdings
antibiotics
drug development
Flag link:
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Reuters
Melinta Therapeutics
Chapter 11
bankruptcy
antibiotics
Flag link:
Biopharma has abandoned antibiotic development. Here’s why we did, too.
Biopharma has abandoned antibiotic development. Here’s why we did, too.
Endpoints
Octagon Therapeutics
drug discovery
drug development
antibiotics
Flag link:
With looming superbug crisis, Iterum misses in a key antibiotic trial — and its shares tumble
With looming superbug crisis, Iterum misses in a key antibiotic trial — and its shares tumble
Endpoints
Iterum
sulopenem
antibiotics
clinical trial
antibiotic resistance
Flag link:
Brii bags rights to tuberculosis drug to further antibiotic push
Brii bags rights to tuberculosis drug to further antibiotic push
Fierce Biotech
Brii Biosciences
China
AN2 Therapeutics
tuberculosis
antibiotics
Flag link:
FDA Approves Talicia To Treat Superbug Linked To Stomach Cancer
FDA Approves Talicia To Treat Superbug Linked To Stomach Cancer
Forbes
superbugs
antibiotics
antibiotic resistance
Talicia
FDA
stomach bug
Helicobecter pylori
Redhill Biopharma
Flag link:
After positive panel vote, Shionogi antibiotic scores US approval
After positive panel vote, Shionogi antibiotic scores US approval
Endpoints
Shionogi
antibiotics
FDA
cUTI
UTIs
Fetroja
Flag link:
CDC report: 35,000 Americans die of antibiotic-resistant infections each year
CDC report: 35,000 Americans die of antibiotic-resistant infections each year
Stat
CDC
antibiotics
antibiotic resistance
Flag link:
As resistance to standard antibiotics grows, RedHill's H. pylori regimen secures FDA approval
As resistance to standard antibiotics grows, RedHill's H. pylori regimen secures FDA approval
Endpoints
WHO
H pylori
Redhill Biopharma
antibiotics
antibiotic resistance
rifabutin
FDA
Flag link:
Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics
Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics
Endpoints
Scott Gottlieb
FDA
antibiotics
drug development
Flag link:
GlaxoSmithKline kick-starts first-of-its-kind late-stage antibiotic test
GlaxoSmithKline kick-starts first-of-its-kind late-stage antibiotic test
Fierce Biotech
GSK
antibiotics
antibiotic resistance
gepotidacin
Flag link:
Researchers Estimate Costs of Exclusivity Extensions to Encourage Antibiotic Development
Researchers Estimate Costs of Exclusivity Extensions to Encourage Antibiotic Development
RAPS.org
legistlation
regulatory
exclusivity
antibiotics
Flag link:

Pages